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Anion transport by ortho-phenylene bis-ureas
across cell and vesicle membranes†
Christopher M. Dias, a Hongyu Li, b Hennie Valkenier, c
Louise E. Karagiannidis,d Philip A. Gale, *e David N. Sheppard b and
Anthony P. Davis *a
Ortho-Phenylene bis-ureas serve as anionophores in cells expres-
sing halide-sensitive yellow ﬂuorescent protein, as well as in syn-
thetic vesicles. Activities can reach high levels, and are strongly
dependent on the deliverability of the transporters.
The development of synthetic anion transporters (aniono-
phores) has become a major theme of supramolecular chem-
istry.1 An important motivation is the potential for aniono-
phores to be applied therapeutically, for example in the treat-
ment of cancer and channelopathies such as cystic fibrosis
(CF).2 Much of the work focuses on using small molecule
anion carriers, which can bind an anion on one side of the
membrane, traverse the membrane and then release the anion
on the other side.2f,3,4
If anionophores are to be exploited in medicine, it is
necessary to show that they can be eﬀective in living cells, and
not just in synthetic bilayer systems such as vesicles. We
recently developed an assay for biological anion transport
which employs Fischer rat thyroid cells expressing the iodide-
sensing yellow fluorescent protein (YFP-FRT cells).5,6 The assay
was applied to anionophores of the “1,5-diaxial” family3 with
steroidal, trans-decalin or cyclohexane scaﬀolds (e.g. 1–3, see
Fig. 1).6a All tested positive for chloride transport, with trans-
decalin 2 showing especially high activity. Transporter 2
showed negligible toxicity to several cell lines, suggesting that
anionophore activity is not necessarily damaging to cells and
raising the hope of “channel replacement therapy” as a treat-
ment for CF.
While the 1,5-diaxial anionophores are known to be excep-
tionally powerful,7 other families have also shown good activity
in synthetic vesicle assays. In particular, ortho-phenylene bis-
ureas (OPBUs) of general structure 4 have proven eﬀective for
Cl−/NO3
−, Cl−/HCO3
−, and Cl−/carboxylate antiport, in some
cases at very low transporter : lipid ratios.8,9 These carriers are
also especially easy to prepare, being accessible from commer-
cially available starting materials in one or two steps. They
thus provide a valuable opportunity for the study of structure–
activity relationships. Here, we report that OPBUs are active in
cells, at levels comparable to the 1,5-diaxial anionophores. We
also explore the eﬀects of substituents which modify lipophili-
city and electronic characteristics, and the correlation between
results in synthetic vesicles and data from the biological assay.
The results highlight the importance of deliverability in the
development of anionophores for biological applications.
The OPBU anionophores employed in this work are shown
in Fig. 2. To ensure high activities (and thus ease of measure-
ment), the urea units were uniformly terminated with 3,5-bis
Fig. 1 1,5-Diaxial anionophores 1–3, previously shown to be active in
YFP-FRT cells and the general structure 4 for the OPBU carriers studied
in the present work.
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(trifluoromethyl)phenyl groups. Studies conducted by our-
selves and others have shown that anionophores bearing this
substituent are often the most powerful derivatives in their
respective series.7,9,10 Bis-urea 4a was known, and had pre-
viously been shown to possess good transport activity in large
unilamellar vesicles (LUVs).9 The new compounds 4b–g were
synthesised by refluxing the appropriate diaminobenzene with
3,5-bis(trifluoromethyl)phenyl isocyanate in DCM. The prepa-
ration of esters 4f and 4g required prior synthesis of the corres-
ponding alkyl diaminobenzoates from 3,4-diaminobenzoic
acid. Full experimental details are given in the ESI.†
To characterise 4a–g, we first investigated their ability to
function as anion receptors by performing NMR titrations in
DMSO-d6/0.5% H2O with tetrabutylammonium chloride as
guest. In all experiments the most significant movements were
observed for the urea NH signals, indicating that they are all
involved in chloride binding.11 Residual distribution analysis
indicated that all receptors bind the anion in both 1 : 1 and
1 : 2 (host : guest) stoichiometries (see ESI† for further discus-
sion) and titration data were subsequently fitted to this model.
The second binding event was found to be very weak in all
cases and 1 : 1 binding is the predominant process. The results
are given in Table 1. In line with previous work, K1:1 values are
rather moderate and not especially sensitive to the type of sub-
stituent present on the central aromatic ring.8,9 For compari-
son, diureidodecalin 2 bound Bu4N
+Cl− with Ka = 680 M
−1
under the same conditions.6a
To assess the transport properties of these molecules in syn-
thetic membranes, we preferred a method which could dis-
tinguish between intrinsic activity (the ability to transport
anions once in the membrane) and overall practical eﬀectiveness
(which also depends on the ability to find and enter the mem-
brane). In the previous studies on OPBUs, transport activity in
LUVs was assayed using an ion selective electrode (ISE) to detect
chloride anions leaving the vesicles.8,9 This method requires that
the test anionophore be externally added to the vesicles after
they have been prepared; this is because preincorporation leaves
the vesicles permeable to anions at all stages of the experiment,
so that chloride eﬄux can occur before the measurement is
initiated. The test thus gives a measure of practical eﬀectiveness,
but cannot be adapted to show intrinsic transport ability.13 For
the present work, we employed an alternative assay which relies
on a halide-sensitive fluorophore (lucigenin) which can be
trapped inside the vesicles. This detects chloride influx, allowing
the experiment to be started by addition of chloride to the exter-
nal solution. Anionophores can therefore be preincorporated in
the vesicles (to measure intrinsic activity) or added externally
(to assess practical eﬀectiveness).6a
To measure intrinsic activity, we prepared LUVs, (∼200 nm
diameter) from 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line (POPC) and cholesterol (7 : 3 ratio) with the putative trans-
porter preincorporated in the membrane. The interior of the
LUVs contained aqueous NaNO3 (225 mM) and lucigenin. The
vesicles were suspended in aqueous NaNO3 (225 mM) and the
experiment commenced by the addition of a pulse of NaCl
Fig. 2 Structures of ortho-phenylene bis-ureas investigated in this
work. Isolated yields for the ﬁnal step of the synthesis are given in brack-
ets. †Yield reported in previous work (see ref. 9).
Table 1 Binding and transport data for OPBUs 4a–g
Compound clog P a
Binding to Bu4N
+Cl− b
Transport in LUVs (initial slope I of
F0/F)
c (s−1)
Deliverability, D d
Transport in YFP-FRT
cellse
Ka, 1:1 (M
−1) Ka, 1:2 (M
−1) Preincorporated External addition |dF/dt| (s−1)
4a 9.9 136 1 0.073 0.041 0.57 0.02
4b 10.4 146 1 0.073 0.027 0.37 0.0023
4c 10.1 157 1 0.042 0.018 0.43 0.0093
4d 8.8 166 3 0.0073 0.012 1.61 0.0071
4e 9.2 146 2 0.011 0.013 1.17 0.00099
4f 10.8 138 3 0.017 0.011 0.66 0.0017
4g 11.6 134 1 0.019 0.0029 0.15 0.0018
a Calculated log P, an estimate of lipophilicity where P is the partition coeﬃcient between n-octanol and water. Values were calculated using
TorchLite (available as freeware from http://www.cresset-group.com). bDetermined by 1H NMR titration in DMSO-d6/0.5% H2O at 298 K. Data
were analysed using a 1 : 1 + 1 : 2 (host : guest) binding model. c Values are proportional to rates of Cl−/NO3
− exchange. Experiments were con-
ducted in 200 nm POPC/cholesterol (7 : 3) LUVs with transporter : lipid = 1 : 25 000. I was obtained by fitting F0/F versus time (0–500 s) to a double
exponential decay function, for further details see ref. 7 and ESI. d Ratio of I from experiments employing external addition/preincorporation of
transporter (see discussion in text). e I−/Cl− exchange mediated by the transporter (50 μM) in YFP-FRT cells. Obtained by fitting the decay in YFP
fluorescence to a first order exponential function and subtracting fluorescence quenching of the vehicle (0.5–1% v/v DMSO).
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(25 mM). The decay in lucigenin fluorescence emission corres-
ponds to an increase in intravesicular chloride concentration.
To obtain values for comparison, the data were expressed as
F0/F (which is proportional to intravesicular chloride concen-
trations) then initial slopes I were obtained using a curve
fitting procedure.7 Decay curves (F/F0) for a series of experi-
ments with transporter : lipid = 1 : 25 000 are shown in Fig. 3,
and corresponding values for I are listed in Table 1.
The experiments revealed that all compounds in this series
possess high intrinsic anionophore activity, clearly measurable
at a very low transporter loading (0.004 mol%). The most
powerful were bis-ureas 4a and 4b, based on halogenated
central scaﬀolds. In the case of 4a, a dose–response study was
performed and showed activity down to transporter : lipid =
1 : 1000k (Fig. S38†).
When comparing the activities of esters 4d–g, there is
clearly a positive correlation between initial rate and the
length of the ester alkyl chain/lipophilicity (Table 1 and Fig. 4,
red circles). In principle this eﬀect could arise due to diﬀerent
amounts of transporter in the membrane; less lipophilic esters
(shorter chains) might be present in lower concentrations due
to leaching from the membrane into the aqueous phase. To
examine this possibility, we conducted a leaching study10c,12
on methyl ester 4d, the least lipophilic member in this series
and thus the most likely to partition into water. Briefly, LUVs
with 4d preincorporated in the membrane were prepared as
previously described. The vesicles were then successively
diluted with aqueous NaNO3 which should result in a loss of
transporter from the lipid bilayers if it were capable of leach-
ing. However, these studies indicated that 4d resides exclu-
sively within the membrane and is not lost to the aqueous
phase (see ESI† for further details). It thus seems that the
longer alkyl chains promote intrinsic transport activity, poss-
ibly by positioning the transporter or complex more favourably
within the membrane.10c,13,14
After measuring the intrinsic activities of OPBUs 4a–g we
next sought to establish how readily they could be delivered by
external addition to membranes (the second component of
practical eﬀectiveness). LUVs were prepared in a manner ana-
logous to that previously described, except that the aniono-
phore was not added to the initial lipid mixture. Instead a
solution of the anionophore in acetone was externally added to
rapidly stirred preformed vesicles to give a notional transporter
to lipid loading of 1 : 25 000. After 5 minutes, NaCl (25 mM)
was added and the decay in fluorescence analysed as before
(Table 1 and ESI†). Deliverability (D) was calculated by dividing
the initial rate of transport from this experiment to that
observed for preincorporated anionophore. If a transporter is
perfectly deliverable, values for D are found to be ≥1 and this
was observed for esters 4d and 4e.15 However, all other OPBUs
tested displayed inferior activity when externally added, indi-
cating that they are not perfectly deliverable (D < 1). Within the
ester series it is evident that deliverability decreases as a func-
tion of lipophilicity (Table 1 and Fig. 4). This has a substantial
eﬀect on the activity of 4g; whereas it was the most powerful
transporter in the ester series when preincorporated inside
vesicles, it is the least active when added externally. Octyl ester
4g would thus be an ideal candidate for further investigation
in coiled-coil driven membrane fusion studies. As demon-
Fig. 3 Chloride transport mediated by OPBUs in 200 nm POPC/chole-
sterol (7 : 3) LUVs as measured using the lucigenin method. The aniono-
phore was preincorporated in the membrane at a transporter : lipid mole
ratio of 1 : 25 000 in all cases.
Fig. 4 Plot of the initial rate of chloride transport induced by esters
4d–g as function of transporter lipophilicity. The transporter was either
preincorporated in the membrane or added externally as a solution in
acetone to preformed vesicles. The notional transporter to lipid loading
was 1 : 25 000 in all experiments.
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strated previously,6b this is a highly eﬃcient method of deliver-
ing lipophilic anionophores to membranes.
Following characterisation of their transport properties in
synthetic membranes, OPBUs 4a–g were tested in cells. For
these studies, we used Fischer rat thyroid cells expressing the
halide sensor YFP-H148Q/I152L (YFP-FRT cells). YFP-FRT cells
were seeded in a 96-well plate and cultured for 3 to 4 days until
90% confluence. The cells were washed twice with phosphate
buﬀered saline (PBS) solution before incubating with a PBS
solution containing the test anionophore (50 μM) for 10 min.
The experiment was commenced by the addition of NaI
(100 mM) and the rate of chloride/iodide exchange measured by
fitting the decay in YFP fluorescence to a first order exponential
function (see ESI† for full experimental details).
All compounds were found to mediate chloride/iodide
exchange in cells leading to a decay in YFP fluorescence
(Fig. 5, Fig. S45† and Table 1). The most active by some
margin was bis-urea 4a, based on the difluoroaromatic
scaﬀold. Reassuringly, transporter 4a was also the most active
when externally delivered to LUVs, and joint first when prein-
corporated. This adds to our confidence that the YFP-FRT
assay does indeed measure anion transport, rather than some
other phenomenon. Anionophore 4a is somewhat more active
than 2, which gave |dF/dt| = 0.013 s−1 in the present assay. The
overall relationship between activity in cells and vesicles is
shown in Fig. 6. Provided the vesicle measurements involve
external addition of anionophore, a rough correlation emerges
(Fig. 6a). There is, however, considerable scatter; the poor per-
formance of dichloride 4b in the cells, despite its good activity
in LUVs, is especially noticeable. This is diﬃcult to explain,
but may result from a specific interaction between 4b and the
natural membrane. The results imply that, while experiments
in LUVs can give some guidance, these synthetic assemblies
are not ideal surrogates for cells and cannot substitute for bio-
logical testing. When results in cells are compared to those in
vesicles with preincorporated OPBU, the correlation is very
poor (Fig. 6b). This highlights the importance of considering
deliverability as well as intrinsic activity when developing bio-
logically active anionophores.6
In conclusion, we have shown that a series of ortho-pheny-
lene bis-urea (OPBU) anionophores are active in cells as well as
synthetic vesicles. The most eﬀective in all assays is bis-urea
4a, based on a difluorinated central scaﬀold. Activities depend
both on electronic factors and lipophilicity. In particular, the
sequence 4d–g illustrates the role of lipophilicity in promoting
intrinsic activity, but the contrary eﬀect on deliverability and
thus on eﬀectiveness in cells. These bis-ureas are readily pre-
pared, so that many other variations are potentially accessible.
They therefore hold promise as tools for obtaining further
insight into anionophore biological activity, and perhaps for
the development of medical applications.
Conﬂicts of interest
There are no conflicts to declare.
Fig. 5 Anion transport mediated by OPBUs (50 μM) in YFP-FRT cells,
determined by ﬁtting the decay in YFP ﬂuorescence to a ﬁrst order
exponential function. Data are shown as the mean ± SEM (n = 16–32
from at least four independent experiments), with ﬂuorescence quench-
ing by the vehicle (0.5–1% v/v DMSO) subtracted.
Fig. 6 Plot of the rate of chloride transport mediated by OPBUs 4a–g
in YFP-FRT cells versus LUVs when (a) externally added or (b)
preincorporated.
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